Table 1.
T2-High | T2-Low |
---|---|
Overexpression of the immune type 2 ways (for example IL-4 and IL-13 genes) | Immune type 2 response is not overexpressed (overexpression of genes related with the inflammasome and superfamilies of interferon and tumour necrosis factor) |
High sputum eosinophilia | High sputum neutrophilia |
High exhaled nitric oxide fraction | - |
High efficiency of omalizumab, mepolizumab, reslizumab and benralizumab | Low efficiency of omalizumab, mepolizumab, reslizumab and benralizumab |